Morning Movers

This news release constitutes a "designated news release" for the purposes of Trilogy Metals Inc.'s prospectus supplement dated May 27,...

CELEBRATION, Fla., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company...

LOS ANGELES, Oct. 6, 2025 /PRNewswire/ -- B. Riley Financial, Inc. (Nasdaq: RILY) (the "Company") today announced that, on October 1,...

ARLINGTON, Va., Oct. 6, 2025 /PRNewswire/ -- The AES Corporation (NYSE: AES) will host a conference call on Wednesday, November 5,...

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for...

HICKSVILLE, N.Y., Oct. 6, 2025 /PRNewswire/ -- Flagstar Financial, Inc. (NYSE: FLG) (the "Company") today announced it has received the...

This news release constitutes a "designated news release" for the purposes of Trilogy Metals Inc.'s prospectus supplement dated May 27,...

LA JOLLA, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep...

OLD GREENWICH, Conn.--(BUSINESS WIRE)--Ellington Financial Inc. (NYSE: EFC) (the “Company”) today announced that it has closed its offering of $400...

Vinci Compass will acquire the remaining 49.9% stake five years after Closing. Verde Asset Management brings R$16 billion in assets...

Geneva, Switzerland, Oct. 06, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on...

SAN CARLOS, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity...

Icovamenib showed a sustained treatment benefit at Week 52 (9 months past the end of treatment) in the severe insulin-deficient...

Los Angeles, CA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the...

SAN FRANCISCO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Serve Robotics Inc. (Nasdaq: SERV), a leading autonomous sidewalk delivery company, today...

PHILADELPHIA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company...

STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a biotechnology company advancing a yield...

Marker Therapeutics initiated Phase 1 RAPID study to investigate Multi-Antigen Recognizing (MAR) T cells as an Off-the-Shelf (OTS) product to...

- Results published in Oxford Academic’s Military Medicine Journal - - After up to 18 months of follow-up patients were...

ROCHESTER, NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (“Syntec Optics” or the “Company”) (Nasdaq: OPTX),...

Improvement observed in MDS-UPDRS scores in first 9 participants enrolled; 90-day follow-up continuing in remaining participants Plasma exposures in patients...

NYSE American: UEC Proceeds to be Used to Accelerate the Development of the United States Uranium Refining & Conversion Corp CORPUS CHRISTI, Texas,...

Public Safety and Homeland Security Macro Tailwinds Remain Strong Heading into the US Federal Government’s Fiscal First Quarter  REDMOND, Wash.,...

This news release constitutes a "designated news release for the purposes of the Company's amended and restated prospectus supplement dated...

This news release constitutes a "designated news release for the purposes of the Company's amended and restated prospectus supplement dated...

The DECLARATION (safety and efficacy vs. placebo) and LIBERTY (exploratory safety head-to-head and combination with mRNA-based COVID vaccination) clinical trials...